Paxlovid is safe, effective and doesn’t cause ‘rebound,’ FDA says
Pfizer’s antiviral COVID-19 treatment Paxlovid is safe and effective at treating adults with mild to moderate COVID-19 who are at high risk of progressing to severe disease, including hospitalization or death, according to a Food and Drug Administration (FDA) staff report.
Published 3 months ago · Washington, United States
Time & Location
Sources are mostly out of (0)